Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) is a publicly traded Healthcare sector company. As of August 7, 2026, TAK trades at $17.42 with a market cap of $53.40B and a P/E ratio of 0.00. TAK moved +2.44% today. Year to date, TAK is +8.96%; over the trailing twelve months it is +19.27%. Its 52-week range spans $12.80 to $18.90. Analyst consensus is buy with an average price target of $29.56. Rallies surfaces TAK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TAK moved +2.44% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $17.42 |
| Market Cap | $53.40B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.31% |
| 52-Week High | $18.90 |
| 52-Week Low | $12.80 |
| Volume | 2.41M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
2 analysts cover TAK: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.56.